The largest database of trusted experimental protocols

Imark 168 1130

Manufactured by Bio-Rad
Sourced in United States

The IMark 168-1130 is a laboratory equipment product manufactured by Bio-Rad. It is a microplate reader that is designed to measure absorbance in microplates.

Automatically generated - may contain errors

7 protocols using imark 168 1130

1

Cell Viability Assay of TiO2-HA Nanoprobes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell viability of RAW 264.7 cells were detected by CCK-8 assay according to the manufacturer's protocol. Briefly, RAW264.7 cells were seeded in 96-well plates (2 × 104 cells/well) and incubated with complete DMEM medium at a 37 °C and 5% CO2 atmosphere for 24 h. Then, 100 μL of diverse concentrations (0, 25, 50, 75 and 100 μg mL−1) of bTiO2-HA, bTiO2-HA-p and wTiO2-HA-p nanoprobes were added into each well respectively. After being incubated for 24 h, cells were washed with PBS for three times and cultured with 100 μL of DMEM medium containing 10 μL CCK-8 solution for another 2 h. The absorbance was performed by a microplate reader (iMark 168–1130, Bio-rad, USA) at 450 nm wavelength. The treated cell viability was calculated as a percentage of the absorbance to control one. Each test was repeated three times.
+ Open protocol
+ Expand
2

Quantification of Tissue Thyroid Hormone

Check if the same lab product or an alternative is used in the 5 most similar protocols
iBAT was collected and weighed following blood removal by perfusion with PBS and was immediately frozen in liquid nitrogen. Then, the iBAT was homogenized in buffer containing 0.1 M phosphate (pH 7.0), 1 mM EDTA, and 4 mM dithiothreitol by sonication (Sonifier-150, Branson) at 4 °C. After centrifugation at 5000 × g for 5 min at 4 °C, homogenates were used for the measurement of tissue T3 content. Levels of serum and tissue T3 were measured by using a T3 (Total) (Mouse/Rat) ELISA Kit (KA0925, Abnova) and microplate reader (iMark 168-1130, BIO-RAD) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

Cytotoxicity Assessment of Nanoassemblies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Methyl thiazolyl tetrazolium (MTT) assay was used to evaluate the cytotoxicity of 4MBA@nanoassemblies for SERS imaging. In DMEM culture medium, MCF-7 cells were first cultured with 10% FBS using 100 units per mL penicillin and 100 mg mL−1 streptomycin in 5% CO2 at 37 °C. MCF-7 cells were seeded at a density of 1 × 104 cells per well in a 96-well culture plate and incubated for 24 h at 37 °C with 5% CO2. Then, various concentrations of 4MBA@AuNCs and Ag@4MBA@AuNCs (0, 25–500 μM) were added to each well. After 24 h of incubation, 10 mL of MTT solution (5 mg mL−1) was added and incubated for 4 h. Subsequently, the media were removed, followed by the addition of 100 mL of dimethyl sulfoxide (DMSO) to dissolve the formazan crystals. Finally, the absorption of each well was measured using a microplate reader (iMark 168-1130, Bio-rad, USA) and the cell viability was calculated.
+ Open protocol
+ Expand
4

Cytotoxicity Evaluation of GNR Nanocarriers

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro cytotoxicity of GNR nanocarrier was measured by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. Typically, 100 μL of MCF-7 cells were seeded in each well of 96-well plates at a density of 1 × 104 cells/ well and incubated for 24 h. Thereafter, the cells were incubated with 100 mL of fresh DMEM with various concentrations of GNR-CTAB, GNR-PSS-PEI, or GNR-PSS-PEI-mPEG-SH containing 10% FBS for another 24 h. Subsequently, 10 μL of MTT (5.0 mg/mL in PBS) was added into each well. After 4 h of incubation, the entire medium with MTT was removed and 100 mL of DMSO was added to each well to dissolve the formed formazan crystals. Finally, the absorbance of each well was measured at 550 nm using a Microplate Reader (iMark 168-1130, Bio-rad) to calculate the cell viability. For the untreated control group, the same volume of fresh culture medium without nanocarrier was added to the plate. Cell viability of each treatment was compared to the untreated control group and expressed as a percentage.
+ Open protocol
+ Expand
5

Ferric Reducing Antioxidant Power Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The free radical scavenging assay was determined as described by Adedapo and Jimoh [25 ]. FRAP reagent in 25 mL of acetate buffer (300 mM, pH 3.6), 2.5 mL of tripyridyltriazine (10 mM), and 2.5 mL of FeCl3·6H2O (20 mM) was warmed and kept in a water bath at 37 °C. Then, 30 μL volume of 1 mg/mL sample was mixed with 900 μL FRAP solution, and then, the mixtures were allowed to stand in the dark for 30 min. Using a microplate absorbance reader (iMark 168–1130, Bio-Rad laboratories, Hercules, CA, USA), the absorbance of the colored result, a ferrous tripyridyltriazine complex, was measured at 595 nm and was expressed as mg gallic acid equivalent/g.
+ Open protocol
+ Expand
6

Colorectal Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both normal colon (FHC; ATCC® CRL-1831™) and colon cancer (HCT-116; ATCC® CCL-247™)) cells were procured from the American Type Culture Collection (ATTC) and maintained in Dulbecco’s Modified Eagle Medium/F-12 (DMEM⁄F12; cat no. D0547.DMEM⁄F12, Sigma-Aldrich, Saint Louis, MO, USA). Both cell types were provided with 2 mM L-glutamine (Catalog #: BE17-605E Lonza, Bornem, Belgium) and 10% fetal bovine serum (FBS) purchased from (CAT.NO.12103C Sigma-Aldrich, St. Louis, MO, USA), 1% penicillin/streptomycin (Lonza, Belgium). Cell incubation was done at 37 °C in a 5% carbon dioxide atmosphere (NuAire). Cell plating at a density equal to 5000 cells was undertaken in triplicate in a plate of 96 wells [46 ]. On the second day, cells were treated with 5-FU or nitazoxanide at the (0.01, 0.1, 1, 10, and 100 µM) concentrations. Cell viability was assessed after 48 h using MTT solution (Promega, Madison, WI, USA) [47 (link)]. 20 μL of MTT dye were transferred to wells and then incubation of the plate was allowed for a period of three hours. Colour intensity was subsequently read at 570 nm employing a BIO-Rad enzyme-linked immunosorbent assay (ELISA) microplate reader (iMark™ #1681130, BIO-Rad, CA, USA). The viability was calculated relative to a control and the IC50 values were determined using the GraphPad prism 7 as previously reported [48 (link),49 (link)].
+ Open protocol
+ Expand
7

Quantitative Glucose Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood and salivary glucose levels were determined using the glucose oxidase peroxidase (GOD-POD) method. Blood and saliva samples were separated into three test tubes and labeled “Blank”, “Standard”, and “Test”. The following steps were implemented: first, add 50 μL of different concentrations of standards to the “Standard; add 40 μL of sample diluent to the wells of the samples to be tested, and then add 10 μL of the samples to be tested; add 100 μL of enzyme-labeled reagents to each well, except for the “Blank”; seal the plate with a sealing film and incubate at 37 °C for 60 min; dilute the 20-fold concentrated washing solution with 20-fold distilled water for later use; remove the sealing membrane, discard the liquid, spin dry, fill each well with washing solution, let set aside for 30 s and discard, repeat 5 times, and pat dry; add 50 μL of color developer A to each well, then add 50 μL of color developer B, gently shake and mix, and develop color at 37 °C for 15 min in the dark; stop adding to each well; terminate the reaction was by adding 50 μL of solution; finally, set the “Blank” to zero, and measure the absorbance (OD value) of each well in sequence at a wavelength of 450 nm with a microplate reader (Bio-Rad iMark, 168-1130, Tokyo, Japan).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!